Klafke Gabriel Baracy, Moreira Gustavo Marçal Schmidt Garcia, Pereira Juliano Lacava, Oliveira Patrícia Diaz, Conceição Fabricio Rochedo, Lund Rafael Guerra, Grassmann André Alex, Dellagostin Odir Antonio, da Silva Pinto Luciano
Núcleo Biotecnologia, Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas - Campus Capão do Leão, CP 354, CEP 96010-900, Pelotas, RS, Brazil; Faculdade de Medicina/Laboratório de Micologia, Universidade Federal de Rio Grande - Rua General Osório, S/N, CEP 96200-190, Rio Grande, RS, Brazil.
Núcleo Biotecnologia, Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas - Campus Capão do Leão, CP 354, CEP 96010-900, Pelotas, RS, Brazil; Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany.
Int J Biol Macromol. 2016 Dec;93(Pt A):913-918. doi: 10.1016/j.ijbiomac.2016.09.062. Epub 2016 Sep 17.
Lectins are non-immune proteins that reversibly bind to carbohydrates in a specific manner. Bauhinia variegata lectin I (BVL-I) is a Gal/GalNAc-specific, single-chain lectin isolated from Bauhinia variegata seeds that has been implicated in the inhibition of bacterial adhesion and the healing of damaged skin. Since the source of the native protein (nBVL) is limited, this study aimed to produce recombinant BVL-I in Pichia pastoris (rBVL-Ip). The coding sequence for BVL-I containing preferential codons for P. pastoris was cloned into the pPICZαB plasmid. A single expressing clone was selected and fermented, resulting in the secretion and glycosylation of the protein. Fed-batch fermentation in 7L-scale was performed, and the recombinant lectin was purified from culture supernatant, resulting in a yield of 1.5mg/L culture. Further, rBVL-Ip was compared to nBVL and its recombinant version expressed in Escherichia coli BL21 (DE3) (rBVL-Ie). Although it was expressed as a monomer, rBVL-Ip retained its biological activity since it was able to impair the initial adhesion of Streptococcus mutans and S. sanguinis in an in vitro model of biofilm formation and bacterial adhesion. In summary, rBVL-Ip produced in Pichia pastoris represents a viable alternative to large-scale production, encouraging further biological application studies with this lectin.
凝集素是一类非免疫蛋白,能够以特定方式与碳水化合物可逆性结合。羊蹄甲凝集素I(BVL-I)是一种从羊蹄甲种子中分离出的、具有半乳糖/ N-乙酰半乳糖胺特异性的单链凝集素,它与抑制细菌黏附以及受损皮肤愈合有关。由于天然蛋白(nBVL)的来源有限,本研究旨在利用毕赤酵母生产重组BVL-I(rBVL-Ip)。将含有毕赤酵母偏好密码子的BVL-I编码序列克隆到pPICZαB质粒中。挑选出一个单表达克隆并进行发酵,实现了该蛋白的分泌和糖基化。进行了7L规模的补料分批发酵,并从培养上清液中纯化出重组凝集素,产量为1.5mg/L培养物。此外,将rBVL-Ip与nBVL及其在大肠杆菌BL21(DE3)中表达的重组形式(rBVL-Ie)进行了比较。尽管rBVL-Ip以单体形式表达,但它保留了其生物活性,因为在生物膜形成和细菌黏附的体外模型中,它能够削弱变形链球菌和血链球菌的初始黏附。总之,毕赤酵母生产的rBVL-Ip是大规模生产的一个可行替代方案,这鼓励了对该凝集素进行进一步的生物学应用研究。